Panic and fear caused by the outbreak of COVID-19 has provoked Moroccan consumers to stockpile many products in cough, cold and allergy (hay fever) remedies. In most cases, consumer decision making was based on future precaution rather than specific need, with customers preparing for extended periods of lockdown as future restrictions seemed uncertain.
Galenica Laboratoires SA is expected to remain leader in cough, cold and allergy (hay fever) remedies in 2020, albeit with a reduced value share. The company is expected to see its lead decreased due to the more selective purchasing behaviour of Moroccan customers during the COVID-19 and as a result of government warnings on particular products.
Together with category leader Galenica Laboratoires SA, Laboratoires Pharma 5 and Bottu SA will continue to contribute to the strong presence of domestic companies in Moroccan cough, cold and allergy (hay fever) remedies in 2020. Laboratoires Pharma 5 and Bottu SA are both expected to see sharp increases in their value shares in 2020 thanks to the success of Rhinomicine for Laboratoires Pharma 5 and Cotipred and Dolirhume for Bottu SA, all of which are expected to increase their value shares in 2020.
In this category, consumers are becoming increasingly careful when selecting products, especially following warnings from the government. The Health Minister, for example has warned consumers about combination products – cough, cold and allergy (hay fever) remedies, who warns that cocktails of different active ingredients can increase the risk of overdose.
Recent serious flu epidemics at the end of the review period combined with the lasting memory of COVID-19 is expected to support growth in cough, cold and allergy (hay fever) remedies during the forecast period. In addition, pollution is also helping to drive sales of cough, cold and allergy (hay fever) remedies, as consumers are increasingly seeking relief from the irritation and respiratory allergies provoked by polluted air.
Self-medication is increasing for coughs and colds in Morocco. Most products to treat these ailments are available without prescription and consumers tend to visit pharmacies to make a purchase.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Morocco with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Morocco, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page